Latest news

Image: Bru-nO/PixabayImage: Bru-nO/Pixabay

EASL 2020: NAFLD

Fatty liver disease affects one in four in Europe, study estimates.

Professor Heiner Wedemeyer of Essen University Hospital.Professor Heiner Wedemeyer of Essen University Hospital.

EASL 2020: Hepatitis D

Bulevirtide shows promise as maintenance therapy for hepatitis D.

Rohit Loomba presenting to EASL 2020.Rohit Loomba presenting to EASL 2020.

EASL 2020: Experimental treatments for NASH/NAFLD

Experimental NASH treatments: Gilead candidates miss primary endpoint but show some benefits.

infohep news

Editors' picks from other sources